Clinical Radiology
Volume 65, Issue 2 , Pages 145-149 , February 2010

Pseudoangiomatous stromal hyperplasia: a study of the mammographic and sonographic features

  • L. Celliers

      Affiliations

    • Department of Radiology, Sir Charles Gairdner Hospital, Nedlands, Western Australia
    • Corresponding Author InformationGuarantor and correspondent: Department of Radiology, Sir Charles Gairdner Hospital, Hospital Avenue, Nedlands, Western Australia, 6009. Tel.: +61 08 9346 2233; fax: +61 08 9346 2091.
    • ,
  • D.D. Wong

      Affiliations

    • PathWest Laboratory Medicine, Department of Anatomical Pathology, Nedlands, Western Australia
    • ,
  • A. Bourke

      Affiliations

    • Department of Radiology, Sir Charles Gairdner Hospital, Nedlands, Western Australia

Received 5 May 2009 ,Revised 13 October 2009 ,Accepted 18 October 2009.

References 

  1. Vuitch MF, Rosen PP, Erlandson RA. Pseudoangiomatous hyperplasia of mammary stroma. Hum Pathol. 1986;17:185–191
  2. Zanella M, Falconieri G, Lamovec J, et al. Pseudoangiomatous hyperplasia of the mammary stroma: true entity or phenotype?. Pathol Res Pract. 1998;194:535–540
  3. Seidman JD, Borkowski A, Aisner SC, et al. Rapid growth of pseudoangiomatous hyperplasia of mammary stroma in axillary gynecomastia in an immunosuppressed patient. Arch Pathol Lab Med. 1993;117:736–738
  4. Sng KK, Tan SM, Mancer JF, et al. The contrasting presentation and management of pseudoangiomatous stromal hyperplasia of the breast. Singapore Med J. 2008;49:e82–85
  5. Ferreira M, Albarracin CT, Resetkova E. Pseudoangiomatous stromal hyperplasia tumor: a clinical, radiologic and pathologic study of 26 cases. Mod Pathol. 2008;21:201–207
  6. Anderson C, Ricci A, Pedersen CA, et al. Immunocytochemical analysis of estrogen and progesterone receptors in benign stromal lesions of the breast. Evidence for hormonal etiology in pseudoangiomatous hyperplasia of mammary stroma. Am J Surg Pathol. 1991;15:145–149
  7. Pruthi S, Reynolds C, Johnson RE, et al. Tamoxifen in the management of pseudoangiomatous stromal hyperplasia. Breast J. 2001;7:434–439
  8. Ibrahim RE, Sciotto CG, Weidner N. Pseudoangiomatous hyperplasia of mammary stroma. Some observations regarding its clinicopathologic spectrum. Cancer. 1989;63:1154–1160
  9. Gow KW, Mayfield JK, Lloyd D, et al. Pseudoangiomatous stromal hyperplasia of the breast in two adolescent females. Am Surg. 2004;70:605–608
  10. Hargaden GC, Yeh ED, Georgian-Smith D, et al. Analysis of the mammographic and sonographic features of pseudoangiomatous stromal hyperplasia. AJR Am J Roentgenol. 2008;191:359–363
  11. Cohen MA, Morris EA, Rosen PP, et al. Pseudoangiomatous stromal hyperplasia: mammographic, sonographic, and clinical patterns. Radiology. 1996;198:117–120
  12. Polger MR, Denison CM, Lester S, et al. Pseudoangiomatous stromal hyperplasia: mammographic and sonographic appearances. AJR Am J Roentgenol. 1996;166:349–352
  13. Levine PH, Nimeh D, Guth AA, et al. Aspiration biopsy of nodular pseudoangiomatous stromal hyperplasia of the breast: clinicopathologic correlates in 10 cases. Diagn Cytopathol. 2005;32:345–350
  14. Lui PC, Law BK, Chu WC, et al. Fine-needle aspiration cytology of pseudoangiomatous stromal hyperplasia of the breast. Diagn Cytopathol. 2004;30:353–355
  15. Ng WK, Chiu CS, Han KC, et al. Mammary pseudoangiomatous stromal hyperplasia. A reappraisal of the fine needle aspiration cytology findings. Acta Cytol. 2003;47:373–380
  16. Powell CM, Cranor ML, Rosen PP. Pseudoangiomatous stromal hyperplasia (PASH). A mammary stromal tumor with myofibroblastic differentiation. Am J Surg Pathol. 1995;19:270–277

PII: S0009-9260(09)00359-6

doi: 10.1016/j.crad.2009.10.003

Clinical Radiology
Volume 65, Issue 2 , Pages 145-149 , February 2010

Article Tools

* Image Usage & Resolution